redetermined under comparable conditions. Blood pressure and weight were recorded daily, and serum electrolytes were determined before and at the end of the 1 week of treatment. In nine additional subjects who were untreated, the peak reactive hyperemia response was determined on two separate occasions 1 week apart.
Results
The six subjects who received fludrocortisone acetate increased their weight by 3.05 ± 0.76 lb (P < 0.01), increased their serum sodium concentration 4.5 ± 1.3 mEq/L (P <0.01), and decreased their serum potassium concentration 0.45 + 0.15 mEq/L (P <0.02). There was no significant change in blood pressure or the circumference of the forearm under the gauge. Resting forearm blood flow decreased from 5.70 ± 1.35 to 4.12±+-0.95 ml/min/100 ml (P<0.05). The peak reactive hyperemia blood flow (RHBF) in the forearm following release of 1 min of arterial occlusion was unchanged by treatment with the mineralocorticoid and salt. However, following release of 5 and 10 min of arterial occlusion, the peak RHBF was significantly reduced (P < 0.02) ( fig. 1) the vascular sodium content also was increased in the six subjects receiving this drug. Indeed, sodium concentration is increased in the peripheral arteries in dogs with experimentally produced congestive heart failure.6
In the six subjects who were to receive the mineralocorticoid, the initial determination of the peak reactive hyperemia blood flow was normal. This was expected since the subjects had no evidence of vascular disease,'4' [16] [17] [18] hypertension,'9 or heart failure.' However, following 1 week of treatment with fludrocortisone and a high salt intake, there was a significant attenuation of the peak reactive hyperemia blood flow response in the forearm after release of 5 and 10 min of arterial occlusion. The peak RHBF following withdrawal of a maximal ischemic stimulus (5 or 10 min of ischemia) has been shown to be a good indicator of the distensibility of the peripheral arterial bed." 14, 1618 Thus, immediately upon release of arterial occlusion, the normal resistance vessels are widely dilated, and the principal determinant of the blood flow to an extremity in terms of resistance to flow becomes that offered by the large arteries and capillary bed. Therefore, the determination of reactive hyperemia blood flow has received wide usage as a circulatory function test in patients in the detection and assessment of atherosclerotic peripheral vascular disease.'4' 16, 17 In addition to atherosclerosis of the peripheral arteries, disease of the resistance vessels themselves also can cause a decrease in the peak reactive hyperemic blood flow. Thus, a significant attenuation of the peak RHBF has been shown with systemic hypertensionl9 and with systemic amyloidosis. '8 Likewise, in congestive heart failure, there is diminished distensibility of the peripheral arterioles.1 Since in both heart failure6 and hypertension20-23 vascular sodium content is increased, it has been postulated that perhaps the cause Crculation, Volume XLI, Apri 1970 of the vascular stiffness shown in the extremities in these two conditions is due to the increased sodium content of the vessels. The finding of a diminished peak RHBF in the present study caused by mineralocorticoidinduced salt retention extends these previous observations and strongly suggests that the vascular stiffness abnormality characteristic of congestive heart failure is, at least in part, the result of increased sodium content in the systemic arterioles. Alternatively, it is also possible that the mineralocorticoid may have increased tissue pressure which by increasing resistance to flow through the capillary bed may have influenced the peak reactive hyperemic response.
